SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WWS who wrote (205)1/23/1999 1:56:00 PM
From: Mike McFarland  Read Replies (1) of 613
 
*Continued stem cell subthread*--diabetes:

Sorry to be posting so much on this one
subject--but as long as I put the subthread
title up there so folks can skip ahead, maybe
that will be okay for now...

I guess the Pittsburgh Post-Gazette went to
Dr. Block because he was close by...he is the
co-director of the Protein Technology Center at
the University of Pittsburgh School of Medicine...

...Block also is trying to apply these techniques to
pancreatic islet cells, insulin-producing cells that
might be used to treat diabetes (snip) He said the Italian-
Canadian study "is good science and it's good functional
science." Unlike Block's experiments in petri dishes, the
scientists accomplished what appears to be a transdifferentiation
of the stem cells in a living animal.


So I would imagine those biotechs focusing on stem cell
research all have research on diabetes going...

so also note this PR from last month...
CytoTherapeutics Obtains Exclusive, Worldwide Licenses to
Technology for Discovering Pancreatic Stem/Progenitor Cells

Proprietary Technology May Speed Discovery Useful in Treatment of Diabetes
biz.yahoo.com

Diabetes had not been at the forefront in my mind--I'd
been focusing my thoughts on CNS and especially Parkinson's.
But this part of the puzzle is also very interesting...especially
if a very small company like ctii, happens to win the race...

Of course I'd be pleased if one of the big cap pharma or
big cap biotech companies realized suddenly that this
microcap stock has a lead over everybody else and simply
made a deal with ctii, or made a bid outright for the company.
Of course who can say if ctii or Geron or one of the big
caps themselves has the lead. I suppose a couple of Ph D's
with the help of a few patent attorneys could do the
exercise...a shame that all most of us can do is throw darts,
but that will have to do.

--Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext